Clinical Trial Update: AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update discusses the Phase 1/Phase 2 study of AK112 and AK104, with or without chemotherapy, in advanced non-small cell lung cancer; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AK104 (PD-1/CTLA-4 bispecific antibody)
• AK112

Snippet

Sponsor: Akeso | Conditions: Advanced Non-small-cell Lung Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING